RGLS
Regulus Therapeutics Inc.
No insider bought or sold Regulus Therapeutics Inc. in the last 12 months
RGLS over the last year
Prices for RGLS aren't in yet.
RGLS after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
41 insider filings since 2016, newest first
Preston Klassen · Pres, Head of R, D
Joseph P Hagan · CEO
Ali Behbahani · 10% owner
Paul Edward Walker · 10% owner
Peter W. Sonsini · 10% owner
Scott D Sandell · 10% owner
Joshua Makower · 10% owner
Mohamad Makhzoumi · 10% owner
Anthony A. Florence Jr. · 10% owner
Carmen Chang · 10% owner
Forest Baskett · 10% owner
Growth Equity Opportunities V, LLC · 10% owner
Joseph P Hagan · President and CEO
Paul Edward Walker · 10% owner
Ali Behbahani · 10% owner
Peter W. Sonsini · 10% owner
Scott D Sandell · 10% owner
David M Mott · 10% owner
Joshua Makower · 10% owner
Mohamad Makhzoumi · 10% owner
Anthony A. Florence Jr. · 10% owner
Carmen Chang · 10% owner
Forest Baskett · 10% owner
Peter J Barris · 10% owner
Growth Equity Opportunities V, LLC · 10% owner
William H Rastetter · Director
Stelios Papadopoulos · Director
Joseph P Hagan · President and CEO
Pascale Witz · Director
Stelios Papadopoulos · Director
Stelios Papadopoulos · Director
Stelios Papadopoulos · Director
William H Rastetter · Director
Stelios Papadopoulos · Director
Timothy Michael Wright · Chief R, D Officer
Joseph P Hagan · President and CEO
Daniel R. Chevallard · CFO
Stelios Papadopoulos · Director
William H Rastetter · Director
Joseph P Hagan · COO
Alnylam Pharmaceuticals, Inc. · 10% owner
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.